Oxford vaccine chief fires back: ‘It’s not about herd immunity’
And Australia's premier science advocacy body agrees the current row over choice of vaccine misses the point
The head of the Oxford Vaccine Group has defended its COVID-19 vaccine against Australian criticisms, saying discussions about herd immunity have distracted from the need to protect people from severe illness.
A debate has emerged over Australia’s plan to vaccine most people with the adenoviral vector COVID-19 vaccine developed by the University of Oxford and AstraZeneca, with some doctors expressing concern that the reported overall efficacy rate of 70% is not enough to reach herd immunity.
